Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02367 GIANT BIOGENE > Detailed Quotes

02367 GIANT BIOGENE

Watchlist
45.300
+1.300+2.95%
Closed  02/03 16:08 CCT
High
45.950
Open
44.000
Turnover
23.24M
Low
42.050
Pre Close
44.000
Volume
528.80K
Market Cap
45.07B
P/E(TTM)
51.54
52wk High
45.950
Shares
995.00M
P/E(Static)
45.57
52wk Low
24.150
Float Cap
45.07B
Bid/Ask %
35.59%
Historical High
45.950
Shs Float
995.00M
Volume Ratio
0.50
Historical Low
24.150
Dividend TTM
--
Div Yield TTM
--
P/B
24.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.05%
Amplitude
8.86%
Avg Price
43.941
Lot Size
200
Float Cap
45.07B
Bid/Ask %
35.59%
Historical High
45.950
Shs Float
995.00M
Volume Ratio
0.50
Historical Low
24.150
Dividend TTM
--
P/B
24.22
Dividend LFY
--
Turnover Ratio
0.05%
Amplitude
8.86%
Avg Price
43.941
Lot Size
200
Price Forecast

News

Comment

No More
Company Overview More
Founded in 2000, Giant Biotech is a high-tech enterprise based on scientific aesthetics. It is a pioneer and leader in the professional skin care industry based on bioactive ingredients in China. It focuses on the three major industry directions of functional skincare products, medical devices, functional foods, and formula food for special medical purposes. The company uses a proprietary synthetic biology technology platform to independently develop and produce various types of recombinant collagen and various rare ginsenosides, and has 79 patents and patent applications. The company's recombinant collagen technology was granted the first patent in the industry in China, and won the second prize of the National Technological Invention Award and the Chinese Patent Gold Award in 2013 and 2016 respectively. Our basic R&D and product development are centered on our proprietary synthetic biology technology. Design and develop recombinant collagen, rare ginsenosides, and other bioactive ingredients using proprietary synthetic biology technology. Based on the synthetic biology technology platform, a diverse and expanding product portfolio has been built for a wide range of consumers in different application scenarios.
CEO: Jianya Yan
Market: Hong Kong motherboard
Listing Date: 11/04/2022
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist